Dominant tolerance and linked suppression induced by therapeutic antibodies do not depend on Fas-Fasl interactions

Transplantation

Volumn 69, Issue 8, 2000, Pages 1683-1689

  Honey, K ^a   Cobbold, S P ^a   Waldmann, H ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; MONOCLONAL ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKIN TRANSPLANTATION; SPLEEN CELL;

EID: 0034720072     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200004270-00026     Document Type: Article

References (38)

1. Induction of tolerance in peripheral T cells with monoclonal antibodies
2. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: Primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies
3. Mechanisms in CD4 antibody-mediated transplantation tolerance: Kinetics of induction, antigen dependency and role of regulatory T cells
4. 'Infectious' transplantation tolerance
5. Amplification of natural regulatory immune mechanisms for transplantation tolerance
6. Induction of 'infectious' tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients
7. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4
8. Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose
9. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment
10. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
11. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen
12. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
13. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
14. A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse
15. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
16. Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to receptor- mediated tolerance and apoptosis
17. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen- stimulated suicide
18. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation- induced apoptosis in T-cell hybridomas
19. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
20. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
21. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen
22. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance
23. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice
24. Fas ligand-induced apoptosis as a mechanism of immune privilege
25. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance
26. A role for CD95 ligand in preventing graft rejection
27. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice
28. Induction of specific T cell tolerance by Fas ligand-expressing antigen- presenting cells
29. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts
30. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction
31. Regulation of the proinflammatory effects of Fas ligand (CD95L)
32. Actively acquired tolerance to foreign cells
33. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
34. T cell suppression in transplantation tolerance through linked recognition
35. An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow
36. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft
37. Linked suppression of skin graft rejection can operate through indirect recognition
38. Radiation and stress-induced apoptosis: A role for Fas/Fas ligand interactions